References
- BallantyneCMHoogeveenRCBangHLipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) studyCirculation20041098374214757686
- BallantyneCMHoogeveenRCBangHThe relation of lipoprotein-associated phospholipase A2 and C-reactive protein to incident stroke in middle-aged men and women: the Atherosclerosis Risk in Communities studyArch Intern Med200516524798416314544
- BlakeGJDadaNFoxJCA prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in womenJ Am Coll Cardiol2001381302611691499
- BrilakisESJosephPMcConnellJPJrHigher levels of lipoprotein-associated phospholipase A2 are associated with higher incidence of cardiovascular events at follow-up independent of C-reactive proteinEur Heart J2005261374415618069
- CaslakeMJPackardCJSucklingKELipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery diseaseAtherosclerosis20001504131910856534
- DadaNKimNWWolfertRLLp-PLA2: an emerging biomarker of coronary heart diseaseExpert Rev Mol Diag200228994
- HakkinenTLuomaJSHiltunenMOLipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesionsArterioscler Thromb Vasc Biol19991929091710591668
- IribarrenCGrossMDDarbinianJARelation of lipoprotein-associated phospholipase A2 mass and activity with coronary artery calcification in young adults: the CARDIA studyArterioscl Thromb Vasc Biol20052517
- KhuseyinovaNImhofARothenbacherDAssociation between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasisAtherosclerosis2005182181816115490
- KoenigWMeisingerCTrischlerGLipoprotein-associated phospholipase A2 and risk of coronary events in apparently healthy middle-aged men with moderately elevated cholesterol. Results from the 14-year follow-up of the MONICA-Augsburg cohort 1984Circulation20041101903815451783
- KolodgieFDBurkeAPTayeALipoprotein-associated phospholipase A2 is highly expressed in macrophages of coronary lesions prone to rupture2004Presented at the Annual Scientific Sessions of the American Heart Association11 Nov 2004New Orleans, LO, USA
- MacpheeCBensonGMShiYLipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic targetExpert Opin Investig Drugs2005146719
- MacPheeCHMooresKEBoydHFLipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitorBiochem J1999338Pt 24798710024526
- MacpheeCHLipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic targetCurr Opin Pharmacol20011121511714085
- OeiHHSVan der MeerIMHofmanALipoprotein-associated phospholipase A2 is associated with risk of coronary heart disease and stroke. The Rotterdam studyCirculation2005111570515699277
- PackardCJO'ReillyDSCaslakeMJLipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study GroupN Engl J Med200034311485511036120
- QuinnMTParthasarathySSteinbergDLysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesisProc Natl Acad Sci U S A198885280593357891
- RossRAtherosclerosis—an inflammatory diseaseN Engl J Med1999340115269887164
- SchaeferEJMcNamaraJRAsztalosBFEffects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjectsAm J Cardiol20059510253215842965
- SudhirKClinical review: lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular diseaseJ Clin Endo Metab20059031005
- TselepisADKarabinaSAStengelDN-linked glycosylation of macrophage derived PAF-AH is a major determinant of enzyme association with plasma HDLJ Lipid Res20024216455411590221
- TsimihodimosVKakafikaATambakiAPFenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteinsJ Lipid Res2003449273412611907